Advances in Percutaneous Coronary Intervention - An Overview

Introduction

Percutaneous coronary intervention (PCI) is a procedure that opens a blocked artery. Arteries are blood veins that transport oxygen-rich blood throughout the body. If arteries are clogged with a fatty, waxy substance called plaque, they may require a percutaneous coronary intervention. Alternatively, one could undergo a percutaneous coronary intervention to remove blockages following a heart attack. Percutaneous coronary intervention is also known as coronary angioplasty.

What Is Percutaneous Coronary Intervention?

A percutaneous coronary intervention (PCI) is a minimally invasive technique that opens clogged coronary (heart) arteries. The percutaneous coronary intervention was previously known as coronary angioplasty with stenting or simply angioplasty. Arteries are the blood veins that transport oxygen-rich blood from the heart to the entire body. A percutaneous coronary intervention treatment involves reopening a clogged artery with a tiny balloon to enhance blood flow.

What Are the Procedures?

Balloon angioplasty is inflating a balloon (typically as part of an integrated medical device that includes a balloon, guidewire, and stent) within the coronary artery to 'crush' the plaque obstructing the arterial walls. Although balloon angioplasty is still commonly used as part of a percutaneous coronary intervention procedure, it is rarely the only activity performed. Procedures often related to percutaneous coronary intervention include:

• Stent implantation.

• Arterial blockage debulking.

• Rotational atherectomy.

• Orbital atherectomy.

• Laser atherectomy.

• Brachytherapy (using a radioactive source to prevent restenosis).

• Coronary intravascular lithotripsy (IVL).

The percutaneous coronary intervention begins with shaving the skin area to be accessible (groin or arm) and swabbing it with a bacteriostatic agent, typically a chlorhexidine-based solution. An introducer needle is introduced into the targeted artery. Once access is established, a "sheath introducer" holds the artery open. This procedure is known as percutaneous access. Catheter systems utilized in percutaneous coronary intervention procedures are frequently fully integrated medical devices. They are commonly referred to as "over-the-wire" (OTW) catheters. Typically, there are two-lumen routes (a hollow within any tubular construction), the bigger one for the very flexible guidewire and the smaller one for inflating and deflating the balloon or inflatable/catheter assembly. When a stent is employed, the stent tube mesh is first compressed onto the balloon portion of the catheter. In its deflated form, it is small enough to fit through relatively narrow peripheral arteries before being inflated by the underlying balloon and pressed firmly against the damaged coronary artery wall. It expands due to pressure applied by pumping physiological saline into the device through the lumen of the still-attached catheter. This placement technique records the inflation time and pressure used.

The cardiologist uses imaging data from intravascular ultrasonography (IVUS) and fluoroscopic imaging (with a radiopaque dye) during the procedure. The information gained from these two sources allows the cardiologist to trace the catheter's course as it travels through the arterial channels. This information is also useful in determining the location and physical properties of the plaque causing artery constriction.

What Are the Recent Advances in Percutaneous Coronary Intervention?

• Introduction to Drug-Eluting Stents: One of the most significant advances in PCI devices has been the introduction of DES, tiny coils of metallic mesh that are put into narrowed or clogged coronary or peripheral arteries to keep them open and increase blood flow.Unlike bare metal stents, drug-eluting stents contain a medication-coated surface that is gradually given, preventing blood clots and subsequent scar tissue formation, which could lead to arterial narrowing (a disease known as restenosis).

• Advances in Polymer Coatings: Using durable polymers in drug-eluting stents could induce stent thrombosis and inflammation. Coatings with biodegradable polymers produced from lactate or glycolate improve medication delivery to the vascular wall. These polymer coatings can be entirely resorbed hydrolysis upon drug release, with no long-term consequences. Although employing such polymers in future generations of data encryption standard systems shows promise, numerous challenges must be overcome before widespread practical adoption.

What Are the Advancements in Antiplatelet Agents and Their Role in Personalized Medicine and Pharmacogenomics?

Advances in dual-antiplatelet therapy have also led to the developing of newer, more potent antiplatelet medications, such as Prasugrel and Ticagrelor. These medications have shown better efficacy than Clopidogrel in lowering the risk of ischemia-related events following PCI.

What Problems Are Treated Using Percutaneous Coronary Intervention?

PCI treats heart diseases in which one or more coronary arteries are constricted or occluded. It can be used to treat persons with stable symptoms, new onset symptoms, or during a heart attack. Conditions that can be treated with PCI are:

1. Coronary Artery Disease: Coronary artery disease is a disorder in which plaque builds up on the walls of the coronary arteries, causing them to narrow and harden. Symptoms of angina include tightness in the chest, neck, back, and shoulders after physical exercise or emotional stress. Patients with angina may experience shortness of breath, heartburn, or indigestion. Total occlusion occurs when an artery becomes entirely stopped. A chronic complete occlusion is defined as a blockage that lasts three months or more.

2. Acute Coronary Syndrome: It refers to disorders in which blood flow to the heart is abruptly decreased or interrupted. Acute coronary syndrome includes heart attacks and unstable angina (new angina symptoms that appear during rest and without emotional stress).

What Are the Risks and Complications of Percutaneous Coronary Intervention?

Complications of percutaneous coronary intervention

All heart treatments include some risk. The risks of a PCI procedure could include:

• The catheter insertion site may bleed or become infected.

• Blood clots on the heart stent.

• Re-narrowing of the artery.

• Stroke.

Percutaneous coronary intervention is a relatively safe technique with little risk of complications. The chance of the artery closing again after a PCI with a drug-eluting stent is less than 5 percent.

What Is the Healing Time Following a Percutaneous Coronary Intervention?

One can resume normal activities within a week of a PCI. If the profession includes physical activity or heavy lifting, one may have to wait longer before returning to work. During PCI rehabilitation, the cardiologist may prescribe blood thinners. These medications, including Clopidogrel, Prasugrel, and Ticagrelor, reduce the risk of blood clots. One should take these medications according to the doctor's advice.

When Should One Go to Visit a Doctor?

After a PCI, contact a healthcare physician immediately if one has:

• Bleeding or discharge near the catheter insertion site.

• Angina (chest discomfort).

• Chills or fever.

• Coolness or numbness where the doctor placed the catheter.

• Syncope refers to dizziness or fainting.

• Dyspnea (shortness of breath).

• Persistent swelling or pain.

Conclusion

PCI remains a highly successful treatment for coronary artery disease, improving symptoms, lowering angina, and improving patient outcomes. Drug-eluting stents have considerably reduced restenosis rates and the need for repeat revascularization treatments compared to bare-metal stents. Antiplatelet and anticoagulant medications prevent stent thrombosis and ischemic problems following PCI. Dual antiplatelet therapy is the standard regimen for reducing thrombotic events after PCI. Drug-eluting stents and de-escalation methods help balance effectiveness with the risk of bleeding. A very short DAPT following PCI with DES indicates tolerance and feasibility compared to a bachelor of management studies. Recent advances in DAPT, such as Prasugrel and Ticagrelor, have shown improved efficacy in preventing ischemic episodes after PCI compared to Clopidogrel. Personalized medicine, which uses pharmacogenomic testing, allows for adjusting antiplatelet medication while reducing bleeding risk.